Objective To describe the factors influencing the reduction of maternal mortality during the 2022–2024 management period at Tartagal Hospital (HT).

Methods Participatory Action Research (PAR) with a qualitative-quantitative analysis. Twelve meetings and interviews were conducted with the healthcare team, along with 10 validated surveys administered to obstetric inpatients (10/12/24), and an analysis of hospital databases.

Results Since 2022, the maternal mortality rate at HT has been reduced to zero. The main contributing factor was improved accessibility through the implementation of intercultural care along the maternal care pathway and respectful childbirth for Indigenous communities, based on the Primary Health Care Program. A total of 59 Community Health Workers participated by monitoring communities, providing priority transportation for at-risk pregnant women, and conducting nutritional follow-ups in coordination with social programs. Five transcultural facilitators (Wichí and Guaraní) provided hospital support. Surveys showed a 90% compliance rate with Law 25.929 (Respectful Childbirth), with effective management of early mother-child contact. A need was identified to redesign wards, bathrooms, and lodging facilities for pregnant women from remote areas to strengthen this model.

Discussion HT demonstrated that intercultural, comprehensive, and territory-based management of pregnancy and childbirth led to a reduction in maternal mortality beginning in 2022. Teamwork and intersectoral collaboration optimized available resources, consolidating a sustainable and effective model for maternal health. However, the greatest challenge lies in maintaining and increasing funding to ensure the continuity of this policy.

The authors have declared no competing interest.

This study did not receive any funding

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Ministry of Health of Salta, Argentina gave ethical approval for this work

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

All data produced in the present work are contained in the manuscript